Literature DB >> 20547433

Synthesis and reactivity studies on new copper(II) complexes: DNA binding, generation of phenoxyl radical, SOD and nuclease activities.

Kaushik Ghosh1, Pramod Kumar, Nidhi Tyagi, Udai P Singh, Vaibhave Aggarwal, Maria Camilla Baratto.   

Abstract

Tridentate ligand PhimpH binds to Cu(II) centre after deprotonation affording a new family of complexes [Cu(Phimp)(H(2)O)](2)(ClO(4))(2) (1), [Cu(Phimp)(2)] (2) and [Cu(Phimp)(L)] (3-5) where L are CH(3)COO(-), SCN(-) and NO(2)(-) respectively. The molecular structures of complexes 1 x CH(3)CN and 3 were determined by X-ray crystallography. Electrochemical studies depicted Cu(II)/Cu(I) couple in the range of -0.50 to -0.65 V vs. Ag/AgCl. EPR spectral studies for complexes 4 and 5 indicated the order of covalent character in 4 > 5 with d(x(2)-y(2)) ground state. Novel copper complexes were synthesized by a tridentate ligand having phenolato, pyridine and azomethine nitrogen donors. Phenoxyl radical complexes were generated; DNA interaction, SOD and nuclease activities were investigated. [corrected] 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20547433     DOI: 10.1016/j.ejmech.2010.05.026

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  Copper(II) Complexes with N,O-Donor Ligands and Ofloxacin Drug as Antibacterial, DNA Interacting, Cytotoxic and SOD Mimic Agent.

Authors:  Parag S Karia; Pankajkumar A Vekariya; Anshul P Patidar; Mohan N Patel
Journal:  Indian J Microbiol       Date:  2015-04-03       Impact factor: 2.461

2.  Nuclease activity via self-activation and anticancer activity of a mononuclear copper(II) complex: novel role of the tertiary butyl group in the ligand frame.

Authors:  Kaushik Ghosh; Pramod Kumar; Varun Mohan; Udai P Singh; Sahba Kasiri; Subhrangsu S Mandal
Journal:  Inorg Chem       Date:  2012-02-28       Impact factor: 5.165

3.  Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compounds.

Authors:  Christian R Kowol; Petra Heffeter; Walter Miklos; Lars Gille; Robert Trondl; Loredana Cappellacci; Walter Berger; Bernhard K Keppler
Journal:  J Biol Inorg Chem       Date:  2011-12-22       Impact factor: 3.358

Review 4.  Development of copper based drugs, radiopharmaceuticals and medical materials.

Authors:  Paweł Szymański; Tomasz Frączek; Magdalena Markowicz; Elżbieta Mikiciuk-Olasik
Journal:  Biometals       Date:  2012-08-23       Impact factor: 2.949

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.